ePRO Resources
-
Addressing The Specific Complexities Of Oncology eCOA Clinical Trials
4/18/2022
What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
10/16/2024
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
The New Standard In Participant-Centric Trials
8/21/2025
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
FDA's Vision On PRO Collection For RWE
9/24/2024
In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.
-
Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC
2/23/2023
Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.
-
eCOA/ePRO: Why Patients Deserve Even More Progress
5/11/2022
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
9/7/2022
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
-
Empowering Caregivers With ePRO Technology For Cancer Support
5/16/2023
Explore the importance of involving caregivers in the care process and how electronic patient-reported outcomes technology can facilitate communication, tracking, and collaboration.
-
Balancing Clinical Care With Digital Utility In Hybrid Trials
10/24/2022
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology
11/20/2024
Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.